Commercial Intelligence
Find the companies worth pursuing now — and the reasons behind them.
LeadLens reads your market and shows where commercial attention belongs now. You see the why-now, the evidence behind each call, and what still needs checking.LeadLens reads your market and shows where commercial attention belongs now.
A researched market in. A short, evidence-backed shortlist of the companies worth pursuing out.
LeadLens is a Commercial Intelligence platform.
It turns fragmented market, company, and change evidence into structured, evidence-backed commercial decisions. It researches markets and companies, identifies meaningful change, weighs timing and evidence, and makes uncertainty explicit.
pressfilingshiringregistryannouncementsexpansion
→✓StructuredCommercial Intelligence
Not a contact database, signal feed, or generic research. A decision about where attention belongs.
- Databases
- show who exists.
- Signal tools
- show what happened.
- Generic research
- gives more information.
- LeadLens
- shows where attention belongs — and why.
LeadLens compresses scattered manual work into one inspectable commercial judgment.
Instead of researching and comparing many companies yourself, see where to focus, why now, what supports the case, what remains uncertain, and what to validate next.
ResearchCompare signalsJudge relevanceCheck timingDecide
compressed into→
The resultA structured commercial judgment
Commercial Intelligence is the decision layer between raw market information and commercial action.
For LeadLens, it structures fragmented company, market, and change evidence into evidence-backed judgments about where commercial attention belongs.
Company levelWhich accounts merit attention — why now, the evidence, uncertainty, and next validation.
Portfolio levelWhere to focus across the set — patterns and what to prioritize, validate, monitor, or hold.
Evidence-backed judgments, not a contact list or a signal feed.
LeadLens delivers Commercial Intelligence at both company and portfolio level.
Company decision briefs, portfolio allocation, visible evidence and uncertainty, and clear next validation steps.
Not a lead list. A commercial decision system.
Prioritizecompany + portfolio level
Why nowA recent, dated development
Dated evidencePublic sources, each dated
UncertaintyWhat still needs checking
Validate nextThe next thing to confirm
PortfolioHow attention is allocated across the set
Share your context. Inspect the intelligence. Decide where to focus.
Tell LeadLens your market and commercial objective. It researches and evaluates the set, then returns Commercial Intelligence you can inspect.
01Share your market + objective
→02Research + evaluation
→03Inspect the intelligence
See a sample brief before you start.
No contact database. No email list. Commercial intelligence for deciding where attention belongs.
From one call to your shortlist
The same reasoning, applied across the market you gave us.
PrioritizeMulti-site healthcare group
New regional facility opened — a clear near-term buying trigger.
ValidateRegional logistics operator
Won a large distribution contract — is the budget owner identified yet?
MonitorSpecialty manufacturer
New production certification — watching for a facility or sourcing move.
Illustrative example — archetypes with synthetic dates and evidence.
How LeadLens thinks
Judgment you can inspect — not a score.
What changedA recent, dated development that makes a company worth attention now — not a static fact.
Evidence + timingThe public sources behind the call, each dated, so you can check the reasoning yourself.
What still needs checkingThe uncertainty stays in view, with the next thing to validate before you commit effort.
One call, in three moves- Before
A mid-market company, no clear reason to engage.
- What changed
Opened a new regional facility — 9 days ago, from a dated public announcement.
- Now
Prioritize — with the open question (who owns procurement?) named as the next check.
Illustrative sample — synthetic companies and evidence.
One-time analysis
Choose the decision you need to make.
The standard of truth never changes. Move up when you need a broader decision, stronger comparison or a portfolio view — not simply more names.
01
Preview
One decisionGet a real decision on where to focus first.
Two companies, fully evaluated — the real intelligence, not a demo
- A clear decision on each, with the evidence and what to validate
- Leave knowing which one deserves your effort first
02
Brief
Shortlist decisionResolve a shortlist into a clear next move.
Six companies compared — which deserve attention, which need a check
- See what strengthens and what weakens each case
- Know exactly what to verify before you commit time
03
Portfolio
Allocation decisionRecommendedSee where your commercial effort belongs across the set.
Twelve companies as one portfolio — where attention should concentrate
- The few that rise above the rest, and the pattern that separates them
- A portfolio view you can plan a quarter of outreach around
04
Premium
Strategic contextUnderstand the context that could change your decision.
The broadest scope, plus the competitive and ecosystem context around it
- Relevant alternatives and what could shift the call before you act
- Decision-ready briefs on the accounts that most warrant the depth
Questions
What to know before you start
What do I receive?
A one-time portfolio of evaluated companies, with a recommendation, evidence, uncertainty and next validation for each.
Do you provide contacts or email lists?
No. LeadLens helps decide which companies deserve investigation; it is not a contact database or outreach tool.
What if no company is strong enough?
LeadLens does not fill a quota with weak cases. The report explains what was investigated and why the current result should be refined, monitored or stopped.
Is a recommendation proof of buying intent?
No. It is an evidence-backed reason to allocate attention, with explicit conditions your team should validate.
Spend your next hour on the right companies.
Start with a bounded analysis or inspect the sample before deciding.